Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis. | サターラ

Population pharmacokinetic modeling of TBA-7371 in healthy participants describes apparent auto-induction of clearance and predicts PK in participants with Mycobacterium tuberculosis.

関連コンテンツ

How the US FDA MIDD paired pilot program helps sponsors

Behind the Science: A Conversation with Lamia Sid-Otmane

Driving Innovation in Pharmacometrics: An Interview with Wynand Smythe, Associate Director at Certara

Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling

Powered by Translations.com GlobalLink Web Software